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KEY POINTS 57 
Question: What is the contemporary US practice of same day discharge (SDD) after elective PCI 58 
with respect to the incidence, variation, trends, costs, and safety outcomes? 59 
Findings: Among 672,470 elective PCIs, across 493 US hospitals, over a decade spanning 2006-60 
2015, SDD occurred infrequently (3.5%) with an extreme 382% hospital variation. However, 61 
SDD was safe short-and long-term and associated with large savings >$5,000/PCI attributed to 62 
reduced supply and room & board costs.  63 
Meaning: Greater and consistent use of SDD could increase overall value in PCI care and save 64 
US hospitals ~$577 million if adopted in the US in the bundled payment era.  65 
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TWEET 66 
#Same day discharge after elective PCI despite being safe, is still rare with extreme hospital 67 
variation. Greater and more consistent use of SDD could increase overall value in PCI care and 68 
save US hospitals ~ $577 million if adopted throughout the US in the bundled payment era.  69 
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ABSTRACT 70 
Importance: Same day discharge (SDD) after elective percutaneous coronary intervention (PCI) 71 
is associated with lower costs, and preferred by patients. However, contemporary patterns of 72 
SDD after elective PCI with respect to the incidence, variation, trends, costs, and safety 73 
outcomes in the US are unknown.  74 
Objectives: We examined 1) incidence and trends in SDD; 2) hospital variation in SDD; 3) the 75 
association between SDD and readmissions for bleeding, acute kidney injury (AKI), acute 76 
myocardial infarction (AMI) or mortality at 30-, 90- and 365 days after PCI; 4) hospital costs of 77 
SDD and its drivers.  78 
Design: Observational cross-sectional and cohort study. 79 
Setting: Nationally representative Premier Healthcare Database (PHD). 80 
Participants: 672,470 elective PCI patients from 493 hospitals between 1/2006-12/2015 with 1 81 
year follow-up. 82 
Exposures: SDD; defined by identical dates of admission, PCI procedure and discharge. 83 
Main outcomes and measures: Death, bleeding requiring transfusion, AKI and AMI at 30-, 90-, 84 
or 365 days after PCI, and costs from hospitals’ perspective, inflated to 2016.  85 
Results: Among 672,470 elective PCIs, the adjusted rate of SDD was 3.5% (95%CI 3.0-4.0%), 86 
which increased from 0.4% in 2006 to 6.3% in 2015. We observed extreme hospital variation for 87 
SDD from 0-83% (median incidence rate ratio (MIRR) 3.82 (95%CI 3.48–4.23), implying an 88 
average (median) 382% excess likelihood of SDD at one vs. another random hospital. Among 89 
SDD (vs. non-SDD [NSDD]) patients, there was no excess risk of death, bleeding, AKI or AMI at 90 
30-, 90- or 365 days.  SDD was associated with large cost savings of $5,128/procedure (95% CI 91 
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$5,006–$5,248), driven by reduced supply and room & boarding costs. A shift from existing SDD 92 
practice to match top decile SDD hospitals could annually save $129 million in our sample and 93 
$577 million if adopted throughout the US. However, residual confounding may be present 94 
limiting the precision of the cost estimates. 95 
Conclusions: Over a decade spanning 2006-2015, SDD after elective PCI was infrequent with 96 
extreme hospital variation. Given the safety and large savings in excess of $5,000/PCI 97 
associated with SDD, greater and more consistent use of SDD could markedly increase overall 98 
value in PCI care.   99 
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INTRODUCTION 100 
 Elective percutaneous coronary intervention (PCI) is common in the United States, 101 
performed in ~half of 600,000 PCI procedures annually.1 With the increasing pressure on 102 
hospitals to improve the quality and value of their services, reducing the costs of elective PCI, is 103 
an important opportunity to explore. In fact, alternative payment models (APMs), such as the 104 
Centers for Medicare and Medicaid Services (CMS) episode payment models (EPMs), commonly 105 
known as “bundled payments”, are accelerating hospitals to prepare for the shift in 106 
reimbursement from ’payment for volume’ to ’payment for value’.2   107 
Same day discharge (SDD) after elective PCI is a potential strategy for improving the 108 
value of PCI as it is associated with greater patient satisfaction, while simultaneously reducing 109 
costs.3-7 Despite observational and randomized data demonstrating safety of SDD, prior studies 110 
from 2004-2008 and 2009-2013 suggest relatively modest uptake of this practice in the United 111 
States.8;9 These results are not surprising, as there have been few systematic efforts towards 112 
implementing SDD after elective PCI, although emerging payments models may create an 113 
urgency to adopt this practice if it is safe and financially beneficial to hospitals. While our prior 114 
work has shown the cost savings from SDD can be substantial, a contemporary analysis of the 115 
incidence, variation, trends, costs, the source of the cost savings and safety outcomes 116 
associated with SDD is needed to define the potential missed opportunity of adopting SDD and 117 
for improving the value of PCI. Therefore, we designed this large, nationally representative 118 
study with the following objectives: 1) To identify contemporary incidence and temporal trends 119 
in SDD after elective PCI; 2) To identify the hospital variation in the practice of SDD after 120 
accounting for hospital case-mix; 3) To identify the hospital costs associated with SDD and the 121 
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sources of cost savings attributable to SDD and 4) To compare the rate of readmissions for 122 
bleeding, acute kidney injury (AKI),  acute myocardial infarction (AMI) and mortality at 30-, 90- 123 
and 365 days after index PCI among SDD and non-SDD (NSDD) patients. 124 
 125 
METHODS 126 
Study participants 127 
We used the Premier Healthcare Database (PHD) (https://www.premierinc.com/), which 128 
is an administrative claims data representing ~20% of all acute care hospitalizations in the 129 
United States for over 15 years and contains socio-demographics, comorbidities, interventional 130 
procedures, medications, costs and outcomes based on International Classification of Disease, 131 
Ninth Revision, Clinical Modification (ICD-9-CM) codes for diagnoses and procedures as 132 
reported by the contributing hospitals. To assess time trends, we included PCI procedures 133 
performed in a 10-year period starting January 1, 2006 and ending December 31, 2015. During 134 
this period 1,443,297 PCIs were available from which we defined elective PCIs using the 135 
CONSORT diagram (Figure 1). To ensure an ‘all-comer’ elective PCI population, we included: A) 136 
patients with a discharge status of ‘outpatient’; OR B) patients with a discharge status of 137 
‘inpatient’ but were admitted as ‘elective’; OR C) patients admitted directly from home, clinic, 138 
primary care or referred by a health maintenance organization (HMO) without an admission 139 
diagnosis of an acute coronary syndrome, but who were admitted as ‘non-elective’, and 140 
discharged as ‘inpatient’. Lastly, we also recognized that a small number of patients with chest 141 
pain or unstable angina are occasionally directly referred from clinics or an emergency room 142 
(ER) visit for an elective cardiac catheterization and ad-hoc PCI. Therefore, we also included 143 
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patients marked as ‘elective’ status on admission and referred with an admission diagnosis of 144 
unstable angina from one of the following sources: home, clinic, primary care or referred by a 145 
HMO or ER and ‘inpatients’ at discharge (D). We believe these inclusions allow capture of the 146 
full spectrum of ‘real-world, all-comer’ elective PCI patients in the US.  147 
Same day discharge 148 
SDD was identified when the date of admission, date of PCI procedure and date of 149 
discharge were identical. Based on this, patients were categorized into two groups – those who 150 
underwent SDD and those who did not (NSDD).  151 
Study outcomes, comorbid conditions and confounders 152 
Information on death, bleeding requiring transfusion, AKI and AMI following discharge 153 
after the index PCI was available at three time points: 30-, 90- and 365 days from the date of 154 
PCI. The follow-up information (within 30-, 90- and 365 days) was limited to survivors from the 155 
index hospitalization and therefore excluded deaths during the index hospitalization. Moreover, 156 
we included information on the following potential site-level and patient-level confounders: 157 
number of beds in the hospital, hospital teaching status, hospital location; primary payer, socio-158 
demographics, procedural characteristics, and prior history of 24 co-morbidities (Table 1). 159 
Costs 160 
Premier uses a micro-costing approach to report department-wise and total costs 161 
related to PCI and hospitalization. Costs were reported as total fixed, total variable and total 162 
costs. We adjusted the costs for inflation using the medical consumer price index10 inflation 163 
rates at the end of the year 2016.  164 
Statistical analyses 165 
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Descriptive statistics included means (±SD) or medians for continuous variables and 166 
frequencies (percentage) for categorical variables, as appropriate. In all multivariable analyses, 167 
we used hierarchical, mixed-effects regression models with hospital as the random effect. This 168 
strategy not only allowed a more robust estimation of the standard errors but also permitted 169 
an assessment of the across-hospital variation. Incidence was estimated using mixed-effects 170 
Poisson regression models. Time trends were assessed using regression models with calendar 171 
year as a covariate. The association of SDD with the study outcomes was determined using 172 
mixed-effects logistic regression models and cost differences associated with SDD were 173 
determined using mixed-effects linear regression. Inter-hospital variation was quantified as 174 
follows: from linear regression models we estimated the intra-class correlation coefficient (ICC) 175 
as the contribution of the hospital-level variance to the overall variance11; from Poisson 176 
regression models we estimated the median incidence rate ratio (MIRR) using the methods of 177 
Larsen and Merlo12 and Rabe-Hesketh and Skrondal13. The MIRR quantifies the average 178 
(median) likelihood that a statistically identical patient presenting at one random hospital vs. 179 
another would undergo SDD. If the MIRR is equal to one, there would be no differences 180 
between hospitals in the likelihood of undergoing SDD. Confidence intervals around the MIRR 181 
were generated to quantitatively define the significance of the variation in SDD across 182 
hospitals.12  183 
To ensure that the association of SDD with outcomes and costs was robust, we 184 
conducted propensity score matching analyses. A multivariable, propensity score was 185 
generated using a single nearest-neighbor matching method. This propensity score model 186 
predicting SDD, adjusted for confounders of age, female gender, Medicare/Medicaid, number 187 
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of hospital beds, teaching hospital, urban hospital, history of diabetes, hypertension, COPD, 188 
peripheral arterial disease, cerebrovascular disease, acute myocardial infarction, prior CABG, 189 
prior PCI, current heart failure, shock, cardiac arrest, multi-vessel disease, IABP used, bare 190 
metal stent used, atherectomy performed, bifurcation lesion PCI, and chronic total occlusion 191 
PCI. Variable-level balance before and after matching was examined using standardized 192 
difference of means, where a difference of <10% is considered good balance, while model-level 193 
balance was examined using the Rubin’s B and Rubin’s R statistics.14 All association analyses of 194 
the association of SDD with outcomes used the propensity score as a covariate in hierarchical 195 
models. Finally, to ensure that our observations and inferences were not influence by likely 196 
confounders, we conducted three additional sets of sensitivity analyses. We repeated all 197 
analyses by excluding 1) low PCI volume hospitals (<50 PCIs/year); 2) transradial PCI; and 3) 198 
‘High-cost’ patients who either decompensated during their PCI requiring hemodynamic 199 
support with Impella or IABP, mechanical ventilation or requiring rotational-, orbital- or LASER 200 
atherectomy.  All statistical analyses were conducted using Stata 12.0 (Stata Corp., College 201 
Station, TX). We used the user-defined programs xtmrho15 to quantify inter-hospital variation 202 
and psmatch216 for the propensity score analyses. Significance was tested at a 2-sided type-1 203 
error rate of 0.05. 204 
 205 
RESULTS 206 
Study participants 207 
From 1,443,297 PCIs, we included 672,470 (46.58%) elective PCI patients from 493 US 208 
hospitals (Figure 1). A total of 62,920 (9.1%) patients underwent SDD. Amongst those 209 
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undergoing radial access, the rate of SDD was also quite low; ~1 in 5 (20.6%) elective radial PCI 210 
patients underwent SDD. The patient characteristics by SDD are detailed in Table 1. Briefly, the 211 
mean age was 65.5 years, 67% were males and 73.1% were white. Most hospitals (40.0%) had 212 
500 or more beds; 92.1% were urban and 49.5% were teaching hospitals. Medicare/Medicaid 213 
accounted for 59.9% of admissions. Bare metal stents (BMS) were used in 16.5% of the cases, 214 
while 20% of cases were for multiple vessels. A small proportion of elective PCI patients 215 
decompensated during the procedure requiring hemodynamic support with Impella or IABP, or 216 
mechanical ventilation or requiring rotational-, orbital- or LASER atherectomy (all < 1%). 217 
Hospitals with <100 beds and use of transradial access were associated with a crude SDD rate 218 
exceeding 20% while the use of low molecular weight heparin and G2B3A, and hospitals with 219 
100-199 beds were associated with crude SDD rates below 5% (Table 1). 220 
Incidence, Trends and Variation in SDD across Hospitals  221 
Figure 2A shows the annual rate of SDD in elective PCIs estimated using mixed effects 222 
Poisson regression with hospital as a random effect. The unadjusted, overall SDD rate (9.1%) 223 
was corrected to 3.5% (95% CI 3.0%-4.0%) after accounting for the significant inter-hospital 224 
variation, suggesting that the higher unadjusted rate is attributable to a few larger centers 225 
performing a larger number of SDD procedures, while the vast majority of smaller centers had 226 
lower rates of SDD. The MIRR was 3.82 (95% CI 3.48–4.23) implying that on average (median) a 227 
patient with identical clinical profile was 382% more likely to undergo SDD at one hospital vs. 228 
another random hospital in our sample. We observed that the adjusted incidence steadily 229 
increased from 0.4% in 2006 to 6.3% in 2015, corresponding to a 19% annual increase over time 230 
which was significant (P for trend <0.001) (Figure 2A, inset). Also, transradial access was 231 
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significantly associated with a higher likelihood of SDD (IRR 1.45, 95% CI 1.40–1.50, p<0.001). 232 
We observed marked variation in SDD rate ranging from 0%-83% (Figure 2B). Over time, the 233 
MIRR declined from 6.66 in 2006 to 3.57 in 2015 (Figure 2B inset). Despite reductions over time, 234 
the variability across hospitals remained very large in 2015 (MIRR 3.57, 95% CI 3.18–4.04).  235 
Association of SDD with outcomes 236 
 In a series of mixed effects, hierarchical, logistic regression models, we examined the 237 
association of SDD with each study outcome – first without propensity adjustment and then 238 
after adjusting for the propensity score (Table 2). From these results, we observed that SDD 239 
was not associated with a higher rate of rehospitalization for bleeding, AKI, AMI or mortality 240 
after discharge.   241 
Association of SDD with hospital costs 242 
Next, we determined the association of SDD with hospital costs and their components. 243 
Figure 3A shows that SDD was associated significantly with reduced fixed, variable and total 244 
costs. The total hospital costs were $5,128 (95% CI $5,006–$5,248) less in SDD patients as 245 
compared to NSDD patients even after accounting for the inter-hospital variation in case-mix 246 
and the propensity score (filled green bar in Figure 3A). We next divided our cohort into two 247 
groups of a) top-decile SDD hospitals (median SDD rate 44.5%, N = 75,694) and b) non-top 248 
decile SDD hospitals (median SDD rate 2.2%, N = 596,776). If the non-top decile hospitals 249 
increased their SDD rate from a median of 2.2% to match the top-decile SDD hospitals' SDD rate 250 
of 44.5%, we estimated annual savings would be $129 million across Premier hospitals and 251 
$433,828 annually for an average hospital performing 200 elective PCIs annually. With 300,000 252 
elective PCIs in the US annually, and assuming a shift in practice from 2.2% SDD to 44.5% SDD 253 
16 
 
amongst the non-top decile hospitals (where 88.74% PCIs performed), the projected cost 254 
savings would be approximately $577 million annually. Assuming a more conservative shift 255 
from 22.3% SDD (BJH NCDR CathPCI institutional report, quarter 4, 2017) to 44.5% SDD the 256 
projected cost savings would still be substantial at $341 million annually. Interestingly, the rates 257 
of adverse outcomes after SDD in top SDD decile hospitals compared to the remaining hospitals 258 
were not significantly different (Supplementary Figure 2) supporting the conjecture that the 259 
above-mentioned shift in practice may be achieved without additional burden of adverse 260 
outcomes. Finally, when we investigated the department-wise components of costs, we found 261 
that the major drivers of the reduced costs were central supply, and room and board costs 262 
(Figure 3B).  263 
Sensitivity analyses 264 
To ensure that results were not swayed by confounders, we conducted three additional 265 
sensitivity analyses. First, low PCI volume hospitals (<50 PCIs per year) could impact the 266 
variation in SDD rates across hospitals. After excluding low-PCI-volume hospitals the adjusted 267 
SDD rate remained unchanged at 3.50% (95% CI 2.97–4.12) with a highly significant and 268 
unchanged inter-hospital variation in SDD rate (MIRR 3.84, 95% CI 3.44–4.33) (Supplementary 269 
Table 1).  270 
Second, since transradial PCI is associated with reduced costs and better outcomes and 271 
patients with transfemoral access were less likely to undergo SDD (8.6%) vs transradial PCI 272 
(20.6%), we excluded transradial PCI and examined if costs and outcomes associated with SDD 273 
amongst the subset of transfemoral PCI were influenced by this exclusion. In patients 274 
undergoing transfemoral PCIs (n=646,182), associations between SDD and the study outcomes 275 
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were unchanged from the overall analyses (Supplementary Table 2) but slightly lower (but 276 
statistically non-significant) adjusted cost savings of $5,095, 95% CI ($4,966-$5,224) in 277 
transfemoral PCI patients, than the overall cost savings of $5,128 (95% CI $5,006–$5,248). 278 
Third, the association of SDD with costs could have been skewed by high cost patients 279 
who decompensated during PCI requiring hemodynamic support, mechanical ventilation or 280 
atherectomy. Excluding these patients (n=7,909, 1.2% of the entire cohort) did not significantly 281 
influence the cost savings (Supplementary Table 3). After excluding these patients, the total 282 
cost savings associated with SDD were reduced to $4,813 (95% CI $4,714-$4,912) in all hospitals 283 
and to $4,790 (95% CI $4,690-$4,891) in high-PCI volume (≥50) hospitals. 284 
Together, our sensitivity analyses demonstrate the study findings are unlikely to have 285 
been confounded by hospital PCI volume, transradial access and patients who decompensated 286 
requiring hemodynamic support, mechanical ventilation or atherectomy. 287 
 288 
DISCUSSION 289 
As hospitals face increasing pressure to provide safe and effective healthcare at lower 290 
cost, SDD has been touted as one strategy to improve the value of PCI.17 To the best of our 291 
knowledge this is the first and only study of contemporary SDD practice in the United States 292 
which builds upon prior studies of SDD with three novel observations. First, not only was the 293 
rate of SDD low with a weakly increasing trend; there was extreme variation in the practice of 294 
SDD across US hospitals, indicating that SDD practices in the US are essentially random, likely 295 
driven by local culture rather than evidence-based practice. Second, in this era of bundled 296 
payments, our study highlights both the economic opportunity of SDD and the source of the 297 
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cost savings. The costs savings attributable to SDD were large in excess of $5,000/case and 298 
driven by reducing central supply and room & board costs. Third, SDD was safe after discharge. 299 
Not only were the 30-, 90- and 365-day adverse outcomes similar for SDD vs. NSDD patients, 300 
but these outcomes were also similar amongst patients undergoing SDD at top-decile hospitals 301 
vs. other hospitals, indicating the sustained safety of SDD across time points and supporting the 302 
conjecture that a shift in practice may be achieved without additional burden of adverse 303 
outcomes.  304 
Our study and prior studies8 indicate that while SDD is increasing perhaps due to greater 305 
adoption of radial access, SDD is still performed only in a minority of elective PCI patients, the 306 
magnitude of the increase has been modest and the room for improvement is substantial. 307 
While a radial approach facilitates SDD, there are cases in which the femoral access remains the 308 
procedural of choice. In a recent study from BJH hospital, St. Louis, MO, in which we observed 309 
cost savings of ~$7,000/case of SDD, more than half of the SDD patients actually underwent 310 
femoral access, using 85% vascular closure devices (VCDs).17 In the present study too, SDD after 311 
femoral access resulted in slightly lower, but still substantial cost savings of $5,095/case. 312 
A unique aspect of Premier is that the costs reflect actual resource use costs obtained 313 
directly from each hospital’s financial department. The cost savings associated with SDD were 314 
large exceeding $5,000/case, due to supply and room & board costs averted. Increasing SDD 315 
from existing low rates to even modestly higher rates could result in a large savings for 316 
hospitals and adoption of SDD could be an important strategy for hospitals participating in 317 
CMS’s, Bundled Payments for Care Improvement Advanced (BPCI Advanced).2 318 
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It is unclear if archaic hospital policies, physician inertia or concerns regarding patient 319 
safety limit the uptake of SDD after elective PCI. While complications are generally rare after 320 
elective PCI, when they do occur, they usually do so in the first few hours after PCI, facilitating 321 
the identification of patients who are unsafe for SDD.3;4;8;19-21  The practice of overnight 322 
observation for all patients after elective PCI for the concern for patient safety is not founded in 323 
evidence. Several randomized trials have confirmed the safety of SDD vs. NSDD.5;6;22 A meta-324 
analysis of 30 observational studies and 7 randomized control trials validated comparable 325 
safety of SDD and NSDD.6 Our study too did not find any excess risk of short- nor long-term 326 
outcomes such as bleeding, AKI, AMI or death among patients undergoing SDD vs. NSDD 327 
groups. Even more powerful is the signal of sustained safety in the 44.5% patients undergoing 328 
SDD at top-decile hospitals who had no excess 30-, 90- and 365 day adverse outcomes than the 329 
2.2% SDD patients at non-top decile SDD hospitals.  330 
We found marked variation with an excess of 300% variation in the likelihood of SDD 331 
across hospitals. This degree of variation suggests that hospitals’ practices for SDD are 332 
essentially random, not explained by patient characteristics nor case mix and implies that a) 333 
some hospitals are more comfortable than others in performing SDD and b) the evidence base 334 
for SDD is not strong, hence SDD practices across hospitals are cultural rather than evidence 335 
based. In a recent study from Barnes Jewish Hospital, St Louis MO we found that developing a 336 
‘patient-centered’ protocol for SDD based on patients’ predicted risks of complications such as 337 
bleeding and AKI led to rapid adoption of SDD in >70% of elective PCI patients and was 338 
associated with $1.8 million cost savings annually in hospitalization costs.17  339 
Limitations 340 
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Our study should be interpreted in the context of several limitations. First, our data until 341 
2015 are lagging behind the current practice by 3 years. More contemporary NCDR CathPCI 342 
registry institutional reports show a substantially higher rate of SDD (22.3% in the last quarter 343 
of 2017). Notwithstanding this, increasing the SDD rate from 22.3% to the top decile rate of 344 
44.5% would still represent substantial cost savings (estimated $341 million). However, it 345 
should be noted that the 22.3% unadjusted SDD rate in the CathPCI registry (or 16.96% in 2015 346 
in Premier) does not account for the extreme inter-hospital variation and the resulting cost 347 
savings would be underestimated, assuming a similar pattern of inter-hospital variation in 348 
CathPCI. Second, angiographic details and procedural complexity are not captured in our data 349 
and the potential for unmeasured confounding remains. Third, outcomes such as bleeding, AKI 350 
and mortality have been ascertained via ICD-9 codes, which could result in misclassification of 351 
outcomes.  Fourth, the cost savings associated with SDD in the study are direct resource use 352 
costs from a hospitals’ perspective. They do not capture the opportunity costs and  353 
underestimate the true cost savings. Fifth, our elective population included a small proportion 354 
of patients with unstable angina, those decompensating during PCI, requiring hemodynamic 355 
support or atherectomy or mechanical ventilation. Their inclusion does not imply they are 356 
eligible for SDD; rather, their inclusion is important to capture the full spectrum of ‘real-world, 357 
all-comer’ elective PCI population in the US. Sixth, the association of SDD with 30-,90- and 365-358 
day outcomes may have a strong likelihood of confounding by indication. Nonetheless, the raw 359 
rates of events are still instructive, since they are very low, it appears that SDD in the patients 360 
selected doesn’t appear to compromise safety. Seven, as exact time stamps of PCI and 361 
discharge were unavailable, we were unable to identify the patients treated late in the day, that 362 
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otherwise would have been eligible for SDD but were kept overnight in view of the late hour. 363 
Eight, this study is unable to identify the specific criteria different hospitals chose for SDD, nor 364 
their angiographic nor PCI characteristics. Lastly, based on the association between transradial 365 
access and SDD, it should be mentioned that the rising trend in SDD may, in part, be 366 
contributed by an increasing trend in the practice of transradial access. 367 
Conclusions 368 
In this large, contemporary and nationally representative study of SDD practices in the 369 
United States, we found that in the decade spanning 2006-2015, despite reduced costs and 370 
sustained safety, SDD was used in a minority of patients; and variation in the practice of SDD 371 
among hospitals was marked.  Given the safety and large savings exceeding $5,000/per case, 372 
greater and more consistent use of SDD could increase the value of PCI and save US hospitals 373 
~$577 million. Taken together, our findings underscore a potentially large missed opportunity 374 
of SDD in the United States.  375 
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TABLES 376 
Table 1: Characteristics of the patients included in the study (n = 672,470) 377 
Characteristic SDD 
(n=60,920) 
NSDD 
(n=611,550) 
SDD 
Rate (%) 
N % N %  
Hospital characteristics          
Total number of beds at hospital          
    000-099 1615 2.65 6161 1.01 20.77 
    100-199 2228 3.66 45740 7.48 4.64 
    200-299 7924 13.01 79188 12.95 9.10 
    300-399 12374 20.31 129,119 21.11 8.75 
    400-499 8015 13.16 110,995 18.15 6.73 
    500+ 28764 47.22 240,347 39.30 10.69 
Hospital Teaching           
    No 29943 49.15 309,533 50.61 8.82 
    Yes 30977 50.85 302,017 49.39 9.30 
Hospital - Urban/Rural           
    Rural 3608 5.92 49,482 8.09 6.80 
    Urban 57312 94.08 562068 91.91 9.25 
Patient and hospitalization 
characteristics         
  
Age* 65.30 10.80 65.55 11.42 --- 
Female gender 17775 29.18 204222 33.39 8.01 
Marital Status ‘Married’ 34492 56.62 341992 55.92 9.16 
Hispanic ethnicity 4070 6.68 26641 4.36 13.25 
Race           
    Black 3790 6.22 48171 7.88 7.29 
    Other 11074 18.18 103544 16.93 9.66 
    Unknown 96 0.16 579 0.09 14.22 
    White 44457 72.98 447366 73.15 9.04 
Insurance Payer           
    Medicare – traditional 24627 40.43 265433 43.40 8.49 
    Managed care  17040 27.97 151239 24.73 10.13 
    Medicare – Managed Care 7995 13.12 68835 11.26 10.41 
    Commercial – Indemnity 3757 6.17 38607 6.31 8.87 
    Medicaid – Traditional 1547 2.54 19214 3.14 7.45 
    Self-pay 890 1.46 16335 2.67 5.17 
Prior history           
23 
 
Diabetes 24289 39.87 256479 41.94 8.65 
Dyslipidemia 49102 80.60 504439 82.49 8.87 
Hypertension 50628 83.11 522231 85.39 8.84 
Smoking 27536 45.20 268956 43.98 9.29 
Congestive Heart Failure 8915 14.63 118726 19.41 6.98 
Prior history of PCI 58893 96.67 607119 99.28 8.84 
Prior history of CABG 2475 4.06 20294 3.32 10.87 
Prior History of AMI 7944 13.04 84123 13.76 8.63 
Prior History of TIA 1175 1.93 12227 2.00 8.77 
Prior History of Hemorrhagic Stroke 4496 7.38 45049 7.37 9.07 
Prior History of Ischemic Stroke 1115 1.83 12483 2.04 8.20 
Acute Renal Failure 3128 5.13 48100 7.87 6.11 
Chronic Renal Disease 6086 9.99 86072 14.07 6.60 
Atrial Fibrillation 6502 10.67 80425 13.15 7.48 
COPD 9118 14.97 109778 17.95 7.67 
Alcohol Abuse 475 0.78 6818 1.11 6.51 
Drug Abuse 269 0.44 3950 0.65 6.38 
Prior History of Any type of Cancer 6965 11.43 74639 12.20 8.54 
Prior history of Heart Transplant 1 0.00 25 0.00 3.85 
Medications during index PCI           
IV Heparin given on day of PCI 6 0.01 50 0.01 10.71 
LMWH given on day of PCI 1037 1.70 86985 14.22 1.18 
Any G2B3A  given on day of PCI 6339 10.41 123589 20.21 4.88 
PCI characteristics           
Drug-eluting stent used 44961 73.80 476717 77.95 8.62 
Bare metal stents used 8116 13.32 102891 16.82 7.31 
Radial access 5424 8.90 20864 3.41 20.63 
Bifurcation during PCI 1035 1.70 15177 2.48 6.38 
FFR during PCI 3477 5.71 17116 2.80 16.88 
IVUS used 7012 11.51 59405 9.71 10.56 
Rotational atherectomy  57 0.09 435 0.07 11.59 
LASER atherectomy  972 1.60 6714 1.10 12.65 
*Columns show mean and standard deviation and not N and %. 378 
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Table 2: Short- and long-term outcomes after same day discharge. 380 
 Incidence* Strength of Association** 
Outcome SDD 
Incidence (95% CI) 
NSDD 
Incidence (95% CI) 
Unadjusted 
OR (95% CI), p 
Propensity adjusted 
OR (95% CI), p 
At 30 days     
    Death 0.29 (0.14 - 0.63) 1.82 (1.68 - 1.98) 0.26 (0.18 - 0.37), <0.0001 0.33 (0.23 - 0.47), <0.0001 
    Transfusion for bleeding 4.23 (3.51 - 5.11) 6.90 (6.25 - 7.61) 0.46 (0.40 - 0.52), <0.0001 0.53 (0.46 - 0.60), <0.0001 
    Acute kidney injury 5.14 (4.39 - 6.02) 9.94 (9.40 - 10.52) 0.44 (0.39 - 0.50), <0.0001 0.53 (0.47 - 0.59), <0.0001 
    Acute myocardial infarction 4.74 (4.01 - 5.61) 7.59 (7.13 - 8.08) 0.56 (0.49 - 0.63), <0.0001 0.62 (0.54 - 0.70), <0.0001 
At 90 days     
    Death 1.60 (1.20 - 2.12) 3.99 (3.74 - 4.26) 0.39 (0.32 - 0.48), <0.0001 0.48 (0.39 - 0.59), <0.0001 
    Transfusion for bleeding 8.91 (7.58 - 10.48) 14.02 (12.71 - 15.47) 0.48 (0.44 - 0.53), <0.0001 0.56 (0.51 - 0.61), <0.0001 
    Acute kidney injury 11.20 (9.87 - 12.72) 20.21 (19.21 - 21.27) 0.51 (0.47 - 0.55), <0.0001 0.60 (0.55 - 0.65), <0.0001 
    Acute myocardial infarction 9.31 (8.18 - 10.59) 14.49 (13.76 - 15.27) 0.58 (0.53 - 0.64), <0.0001 0.65 (0.59 - 0.71), <0.0001 
At 1 year     
    Death 5.39 (4.63 - 6.28) 10.74 (10.17 - 11.33) 0.45 (0.40 - 0.51), <0.0001 0.54 (0.48 - 0.61), <0.0001 
    Transfusion for bleeding 21.10 (18.57 - 23.98) 30.66 (27.88 - 33.71) 0.55 (0.52 - 0.58), <0.0001 0.63 (0.59 - 0.66), <0.0001 
    Acute kidney injury 30.61 (27.96 - 33.50) 49.35 (47.03 - 51.79) 0.57 (0.54 - 0.60), <0.0001 0.66 (0.63 - 0.70), <0.0001 
    Acute myocardial infarction 23.17 (21.17 - 25.35) 33.31 (31.86 - 34.82) 0.64 (0.60 - 0.68), <0.0001 0.70 (0.66 - 0.74), <0.0001 
 381 
*Incidence rates are shown per 1000 PCIs and are estimated using hierarchical, mixed effects Poisson regression model that used 382 
hospitals as the random effects. 383 
** All results are from hierarchical logistic regression models that used hospital site as the random effect. 384 
OR, odds ratio; CI, confidence interval; SDD, same day discharge; NSDD, not same day discharge; CI, confidence interval. 385 
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FIGURE LEGENDS 387 
Figure 1: Flowchart to identify elective PCI population in Premier. 388 
PCI – percutaneous coronary intervention, ACS – acute coronary syndrome, ER – emergency 389 
room, UA – unstable angina. 390 
Figure 2: Temporal trends (panel A) and hospital variation (panel B) in the practice of SDD 391 
after elective PCI in the United States. 392 
Inset A shows a magnified, scaled graph of the temporal trend for SDD, with a regression 393 
coefficient of 1.19, implying an increase of 19% annually over the base line rate in 2006. 394 
Panel B shows a bubble plot of the rate of SDD by hospitals performing >50 PCIs annually. Size 395 
of bubbles is proportionate to hospitals’ annual PCI volume.  396 
Inset B shows the temporal trend in the median incidence rate ratio (MIRR) for SDD for 397 
hospitals across the study years, implying a substantial but decreasing variation in SDD practices 398 
across hospitals. 399 
Figure 3: Cost savings associated with SDD (panel A) and drivers of cost savings attributable to 400 
SDD (panel B). 401 
ICU – intensive care unit, EKG – electrocardiogram, U – unadjusted, A – adjusted. ICC – 402 
intraclass correlation coefficient.  403 
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FIGURES 404 
Figure 1: Flowchart to identify elective PCI population in Premier. 405 
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Figure 2: Temporal trends (panel A) and hospital variation (panel B) in the practice of SDD after elective PCI in the United States. 408 
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 410 
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Figure 3: Cost savings associated with SDD (panel A) and drivers of cost savings attributable to SDD (panel B). 412 
413 
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